| scholarly article | Q13442814 |
| P2093 | author name string | Xuan Zhang | |
| Haibo Liu | |||
| Thomas R Kosten | |||
| Da Chun Chen | |||
| Xiang Yang Zhang | |||
| Cunbo Li | |||
| Shilong Sun | |||
| Mei Hong Xiu | |||
| Fu De Yang | |||
| Wen Jun Li | |||
| Ya Qin Yu | |||
| Yan Qiu Yang | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| dyskinesia | Q629444 | ||
| P304 | page(s) | 37-40 | |
| P577 | publication date | 2011-07-20 | |
| P1433 | published in | Neuroscience Letters | Q7002625 |
| P1476 | title | Decreased serum brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia | |
| P478 | volume | 502 |
| Q36600804 | A Review of Brain-derived Neurotrophic Factor as a Candidate Biomarker in Schizophrenia |
| Q48678119 | Altered BDNF is correlated to cognition impairment in schizophrenia patients with tardive dyskinesia. |
| Q33566832 | BDNF Val66Met polymorphism and antipsychotic-induced tardive dyskinesia occurrence and severity: a meta-analysis |
| Q35284133 | Decreased serum levels of brain-derived neurotrophic factor in schizophrenic patients with deficit syndrome |
| Q48694105 | Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia |
| Q38209971 | Neurodegenerative aspects in vulnerability to schizophrenia spectrum disorders. |
| Q26784904 | Omics-Based Biomarkers: Application of Metabolomics in Neuropsychiatric Disorders |
| Q48507006 | Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications |
| Q38911685 | Pharmacogenetics of tardive dyskinesia: an updated review of the literature |
| Q37615022 | Vascular endothelial growth factor and brain-derived neurotrophic factor in quetiapine treated first-episode psychosis |
Search more.